Keryx Biopharmaceuticals Inc(KERX)
3.36
Change: 0 (0)
As of Wed 04/03/2019 09:33 PM% Of Value
Growth
Value Per Share
:
:
:
-178.30
100.00
-3.4800 (as of 12/12/2018)
NO DATA TO DISPLAY
NO DATA TO DISPLAY
NO DATA TO DISPLAY
NO DATA TO DISPLAY
Fundamentals Data
| Open | 3.44 | Dividend | 106 |
| Close Price | 3.36 | DivYield | 0 % |
| High | 3.465 | Growth | 0.0 |
| Low | 2.965 | Growth% | 100.00 |
| P/e | -3.646 | Volume | 2.5 M |
| P/b | -1.46 | Market Capital | 0.0 |
| Highest High | 8.25 | Lowest Low | 4.69 |
| 50 Days Moving Average | 3.03 (as of 19/07/2019) | 50 Days Moving Average Percentage | -35.984 (as of 19/07/2019 |
| Industry: Major Pharmaceuticals |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 | Year2 | Year3 | Year4 | Current Year / 2017 |
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 60.6 M |
| Cap Spending | 0.0 | 0.0 | 0.0 | 0.0 | -1.2 M |
| Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 140.3 M |
| Operating Cash Flow | 0.0 | 0.0 | 0.0 | 0.0 | -101.6 M |
| Free Cash Flow | 0.0 | 0.0 | 0.0 | 0.0 | -94.7 M |
| Free Cash Flow Per Share | -0.827 | ||||
| Total liabilities | 0.0 | 0.0 | 0.0 | 0.0 | 125.0 M |
| Total cash | 0.0 | 0.0 | 0.0 | 0.0 | 93.5 M |
| ROE% | 325.416 | ||||
| Outstanding Shares | 0.0 | 0.0 | 0.0 | 0.0 | 119.1 M |
| P/E | -3.646 | ||||
| P/S | 9.826 | ||||
| Revenue USD | 0.0 | 0.0 | 0.0 | 0.0 | 60.6 M |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|